XML 16 R4.htm IDEA: XBRL DOCUMENT v3.22.1
CONSOLIDATED STATEMENTS OF OPERATIONS (LOSS) - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Revenues:    
Revenues $ 0 $ 0
Operating expenses:    
Research and development 15,477 4,759
General and administrative 7,461 5,877
Total operating expenses 22,938 10,636
Operating loss (22,938) (10,636)
Other income (expense):    
Foreign exchange gains (losses) 44 22
Interest income 16 42
Other income, net 144 891
Total other income, net 204 955
Loss before taxes (22,734) (9,681)
Income tax benefit 3,847 1,236
Net loss (18,887) (8,445)
Dividend on convertible exchangeable preferred shares (201) (201)
Beneficial conversion feature of Series B preferred stock 0 (3,775)
Net loss applicable to common shareholders $ (19,088) $ (12,421)
Basic and diluted earnings per common share:    
Net loss per share - Basic $ (2.14) $ (3.42)
Net loss per share - diluted $ (2.14) $ (3.42)
Weighted average common shares outstanding Basic 8,926,173 3,633,385
Weighted average common shares outstanding diluted 8,926,173 3,633,385